Sun Pharmaceutical Industries Ltd. — Call Transcript 2023

Feb 1, 2023

Sun Pharmaceutical Industries Limited SUN HOUSE, CTS No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, India Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343 CIN: L24230GJ1993PLC019050 www.sunpharma.com

==> picture [61 x 83] intentionally omitted <==

01 February 2023

National Stock Exchange of India Limited, Exchange Plaza, 5th Floor, Plot No. C/1, G Block, Bandra Kurla Complex, Bandra (East), Mumbai- 400 051 Scrip Symbol: SUNPHARMA

BSE Limited, Market Operations Dept. P. J. Towers, Dalal Street, Mumbai - 400 001 Scrip Code: 524715

Sub: Investor call audio recording

Dear Sir / Madam,

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, further to our intimation dated 17[th] January 2023 regarding earnings call, the audio recording of the call held today is available on our website. The same can be accessed through below link:

https://sunpharma.com/wp-content/uploads/2023/02/Q3-FY22-23-SPIL-Earnings-Call-AudioRecording.mp3

This is for your information and record.

Thanking you,

Yours faithfully,

For Sun Pharmaceutical Industries Limited

ANOOP Digitally signed by ANOOP ANJANIKUMAR DESHPANDE DN: c=IN, o=Personal, postalCode=411038, st=Maharashtra, ANJANIKUMAR serialNumber=EFFDD2957A082F211A0213A23 B583DE528E4413FBFAC2175693E06EF12FFD7 D9, cn=ANOOP ANJANIKUMAR DESHPANDE DESHPANDE Date: 2023.02.01 08:18:30 +05'30' (Anoop Deshpande) Company Secretary and Compliance Officer

Registered Office : SPARC, Tandalja, Vadodara – 390 012 India. Reaching People. Touching Lives